NCT06906757View on ClinicalTrials.gov

Preterm Rupture of Membranes Optimising Antibiotics Trial

NANot yet recruitingINTERVENTIONAL
Enrollment

3,900

Participants

Timeline

Start Date

September 30, 2025

Primary Completion Date

December 31, 2029

Study Completion Date

December 31, 2050

Conditions
PPROMPreterm
Interventions
DRUG

Erythromycin 250mg + placebo

Antibiotic.

DRUG

Azithromycin 500mg + placebo

Antibiotic.

DRUG

Erythromycin 250mg and Amoxicillin 500mg

Antibiotics.

All Listed Sponsors
lead

University of Melbourne

OTHER

NCT06906757 - Preterm Rupture of Membranes Optimising Antibiotics Trial | Biotech Hunter | Biotech Hunter